153 related articles for article (PubMed ID: 10727518)
1. Antisense inhibition of delta-opioid receptor gene function in vivo by peptide nucleic acids.
Fraser GL; Holmgren J; Clarke PB; Wahlestedt C
Mol Pharmacol; 2000 Apr; 57(4):725-31. PubMed ID: 10727518
[TBL] [Abstract][Full Text] [Related]
2. Effects of antisense oligonucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats.
Negri L; Broccardo M; Lattanzi R; Melchiorri P
Br J Pharmacol; 1999 Dec; 128(7):1554-60. PubMed ID: 10602336
[TBL] [Abstract][Full Text] [Related]
3. Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats.
Jutkiewicz EM; Walker NP; Folk JE; Rice KC; Portoghese PS; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2005 Mar; 312(3):1314-20. PubMed ID: 15574687
[TBL] [Abstract][Full Text] [Related]
4. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
[TBL] [Abstract][Full Text] [Related]
5. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
6. Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.
Jutkiewicz EM; Kaminsky ST; Rice KC; Traynor JR; Woods JH
J Pharmacol Exp Ther; 2005 Oct; 315(1):414-22. PubMed ID: 16014751
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic social stress on delta-opioid receptor function in the rat.
Pohorecky LA; Skiandos A; Zhang X; Rice KC; Benjamin D
J Pharmacol Exp Ther; 1999 Jul; 290(1):196-206. PubMed ID: 10381776
[TBL] [Abstract][Full Text] [Related]
8. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats.
Jutkiewicz EM; Eller EB; Folk JE; Rice KC; Traynor JR; Woods JH
J Pharmacol Exp Ther; 2004 Apr; 309(1):173-81. PubMed ID: 14722329
[TBL] [Abstract][Full Text] [Related]
9. Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA.
Negri L; Lattanzi R; Borsodi A; Toth G; Salvadori S
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):203-11. PubMed ID: 10355826
[TBL] [Abstract][Full Text] [Related]
10. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
Hosohata K; Varga EV; Alfaro-Lopez J; Tang X; Vanderah TW; Porreca F; Hruby VJ; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 2003 Feb; 304(2):683-8. PubMed ID: 12538822
[TBL] [Abstract][Full Text] [Related]
11. Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice.
Turner BJ; Cheah IK; Macfarlane KJ; Lopes EC; Petratos S; Langford SJ; Cheema SS
J Neurochem; 2003 Nov; 87(3):752-63. PubMed ID: 14535957
[TBL] [Abstract][Full Text] [Related]
12. Selective growth inhibition of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans by antisense peptide nucleic acids.
Sugimoto S; Maeda H; Kitamatsu M; Nishikawa I; Shida M
Mol Cell Probes; 2019 Feb; 43():45-49. PubMed ID: 30471338
[TBL] [Abstract][Full Text] [Related]
13. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
14. Tolerance to high-internalizing δ opioid receptor agonist is critically mediated by arrestin 2.
Vicente-Sanchez A; Dripps IJ; Tipton AF; Akbari H; Akbari A; Jutkiewicz EM; Pradhan AA
Br J Pharmacol; 2018 Jul; 175(14):3050-3059. PubMed ID: 29722902
[TBL] [Abstract][Full Text] [Related]
15. miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.
Fabani MM; Gait MJ
RNA; 2008 Feb; 14(2):336-46. PubMed ID: 18073344
[TBL] [Abstract][Full Text] [Related]
16. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
[TBL] [Abstract][Full Text] [Related]
17. Altering behavioral responses and dopamine transporter protein with antisense peptide nucleic acids.
Tyler-McMahon BM; Stewart JA; Jackson J; Bitner MD; Fauq A; McCormick DJ; Richelson E
Biochem Pharmacol; 2001 Oct; 62(7):929-32. PubMed ID: 11543728
[TBL] [Abstract][Full Text] [Related]
18. Mu and delta opioid-stimulated [35S]GTP gamma S binding in brain and spinal cord of polyarthritic rats.
Cichewicz DL; Cox ML; Welch SP; Selley DE; Sim-Selley LJ
Eur J Pharmacol; 2004 Nov; 504(1-2):33-8. PubMed ID: 15507218
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
[TBL] [Abstract][Full Text] [Related]
20. Antisense properties of peptide nucleic acid.
Larsen HJ; Bentin T; Nielsen PE
Biochim Biophys Acta; 1999 Dec; 1489(1):159-66. PubMed ID: 10807005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
